The results of CD4+STAT-4+ lymphocytes (Figure 8A) and CD4+IFN-γ+ (Figure 8B) in BAL showed a significant increase in the COPD group compared to the Basal group and a significant reduction in the PBM treated group. This evidence concerns the gene IFNG and chronic obstructive pulmonary disease.